Protective Insurance Corp.
Protective Insurance Corp. (PTVCA) relating to its proposed acquisition by The Progressive Corporation. Under the terms of the agreement, PTVCA shareholders will receive $23.30 in cash per share.
Protective Insurance Corp. (PTVCA) relating to its proposed acquisition by The Progressive Corporation. Under the terms of the agreement, PTVCA shareholders will receive $23.30 in cash per share.
Apex Global Brands, Inc. (APEX) relating to its proposed merger with Galaxy Universal LLC. Under the terms of the agreement, APEX shareholders will receive $2.00 in cash per share.
Regal Beloit Corp. (RBC) relating to its proposed merger with Rexnord Corporation. Under the terms of the agreement, RBC shareholders will own 61.4% of the combined company, with Rexnord owning the remaining 38.6%.
Forterra, Inc. (FRTA) relating to its proposed acquisition by Quikrete Holdings, Inc. Under the terms of the agreement, FRTA shareholders will receive $24.00 in cash per share.
Cooper Tire & Rubber Company (CTB) relating to its proposed merger with The Goodyear Tire & Rubber Company. Under the terms of the agreement, CTB shareholders will receive 0.907 shares of Goodyear common stock and $41.75 in cash per share.
Osprey Technology Acquisition Corp. (SFTW) relating to its proposed merger with BlackSky Holdings, Inc. Under the terms of the agreement, SFTW will merge into BlackSky, with BlackSky emerging as a publicly traded company.
PRA Health Sciences, Inc. (PRAH) relating to its proposed acquisition by ICON plc. Under the terms of the agreement, PRAH shareholders will receive 0.4125 shares of ICON stock and $80.00 in cash per share.
Reinvent Technology Partners (RTP) relating to its proposed merger with Joby Aviation. Under the terms of the agreement, RTP will merger with and into Joby, with Joby emerging as a publicly traded company.
Pandion Therapeutics, Inc. (PAND) relating to its proposed acquisition by Merck. Under the terms of the agreement, PAND shareholders will receive $60.00 in cash per share.
Longevity Acquisition Corp. (LOAC) relating to its proposed merger with 4D Pharma PLC. Under the terms of the agreement, LOAC shareholders will receive 7.5315 shares of 4D Pharma per share.